FABRIS, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 10.570
AS - Asia 8.250
EU - Europa 6.053
SA - Sud America 1.516
AF - Africa 246
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 14
Totale 26.704
Nazione #
US - Stati Uniti d'America 10.299
SG - Singapore 2.974
CN - Cina 1.865
IT - Italia 1.724
BR - Brasile 1.159
VN - Vietnam 927
HK - Hong Kong 894
SE - Svezia 713
DE - Germania 590
KR - Corea 449
FR - Francia 394
RU - Federazione Russa 366
PL - Polonia 359
GB - Regno Unito 320
FI - Finlandia 297
NL - Olanda 282
IN - India 221
BG - Bulgaria 208
IE - Irlanda 185
JP - Giappone 178
UA - Ucraina 178
TR - Turchia 143
AR - Argentina 137
CA - Canada 129
MX - Messico 98
CH - Svizzera 89
ID - Indonesia 89
AT - Austria 88
BD - Bangladesh 81
MA - Marocco 68
ES - Italia 67
ZA - Sudafrica 57
IQ - Iraq 52
EC - Ecuador 50
CO - Colombia 48
PK - Pakistan 48
AU - Australia 45
IR - Iran 42
VE - Venezuela 33
SA - Arabia Saudita 32
PH - Filippine 30
EG - Egitto 29
RO - Romania 29
BE - Belgio 27
PE - Perù 26
TW - Taiwan 25
DK - Danimarca 23
KZ - Kazakistan 23
CL - Cile 21
SN - Senegal 21
TH - Thailandia 21
CZ - Repubblica Ceca 20
PY - Paraguay 20
DZ - Algeria 19
MY - Malesia 18
TN - Tunisia 17
UY - Uruguay 17
AE - Emirati Arabi Uniti 15
UZ - Uzbekistan 15
GR - Grecia 13
JO - Giordania 12
KE - Kenya 12
AZ - Azerbaigian 11
AL - Albania 10
IL - Israele 10
MK - Macedonia 10
EU - Europa 9
LT - Lituania 9
NZ - Nuova Zelanda 9
HU - Ungheria 8
LB - Libano 8
NP - Nepal 8
BH - Bahrain 7
JM - Giamaica 7
PA - Panama 7
RS - Serbia 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
HR - Croazia 6
KG - Kirghizistan 6
MN - Mongolia 6
OM - Oman 6
BO - Bolivia 5
LA - Repubblica Popolare Democratica del Laos 5
PT - Portogallo 5
SV - El Salvador 5
CY - Cipro 4
KW - Kuwait 4
LV - Lettonia 4
NG - Nigeria 4
NO - Norvegia 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
CM - Camerun 3
GE - Georgia 3
GT - Guatemala 3
KH - Cambogia 3
MD - Moldavia 3
NI - Nicaragua 3
Totale 26.657
Città #
Singapore 1.824
Ashburn 1.303
Fairfield 909
Hong Kong 857
Chandler 668
San Jose 654
Woodbridge 628
Wilmington 463
Seattle 444
Houston 437
Seoul 424
Beijing 422
Ann Arbor 408
Hefei 381
Ho Chi Minh City 309
Trieste 309
Cambridge 291
Boardman 264
Princeton 259
Chicago 235
Jacksonville 222
Sofia 206
Helsinki 195
Lauterbourg 181
Hanoi 179
Dublin 178
Zgierz 169
Los Angeles 168
Santa Clara 166
Moscow 165
Columbus 159
Warsaw 156
Milan 147
The Dalles 136
Council Bluffs 123
Dallas 117
New York 101
London 97
Tokyo 96
Frankfurt am Main 95
Rome 87
São Paulo 83
Munich 78
Buffalo 77
Nuremberg 75
Izmir 71
Shanghai 70
Dearborn 63
San Diego 59
Venezia 50
Bern 48
Mumbai 43
Montreal 42
Vienna 41
Washington 41
Düsseldorf 40
Da Nang 39
Rostock 39
Grafing 38
Turin 38
Lappeenranta 37
Orem 37
Guangzhou 36
Haiphong 36
Johannesburg 35
Redwood City 34
Toronto 33
Mexico City 32
Redondo Beach 31
Turku 31
Atlanta 30
Rio de Janeiro 30
Amsterdam 29
Casablanca 28
Dong Ket 26
Jinan 26
Shenzhen 26
Brussels 24
Brooklyn 23
Chennai 23
Des Moines 23
Nanjing 23
Naples 23
Denver 22
Jakarta 22
Madrid 22
Dakar 21
Phoenix 21
Zurich 21
Baghdad 20
Belo Horizonte 20
Bologna 20
Guayaquil 20
Istanbul 20
Lima 19
Tianjin 19
Bremen 18
Curitiba 18
Dhaka 18
Florence 18
Totale 16.682
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 519
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial 502
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 396
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 395
Coronary covered stents 332
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 297
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 285
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 280
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 271
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 264
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 264
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? 255
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 254
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 252
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 248
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 248
Treatment of Functional Mitral Regurgitation in Heart Failure 242
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 242
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 240
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 240
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 239
Impact of patient delay in a modern real world STEMI network 235
The role of clinical observation: Red flag 5-right ventricular involvement, arrhythmogenic right ventricular cardiomyopathy and associated phenotypes 228
The role of clinical observation: Red flag 1-cardiomyopathies and skeletal muscle involvement 226
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 221
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 218
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program 217
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature 215
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 214
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 212
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts 212
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 211
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 209
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study 204
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 198
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 196
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 192
The role of clinical observation: red flag 8 - Cardiomyopathies in the first year of life and pediatric cardiomyopathies. 191
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 190
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. 188
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 188
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 188
Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention 179
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy 179
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 179
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 169
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 169
Clinical Spectrum of PRKAG2 Syndrome 167
Angiopatia amiloide cerebrale e occlusione dell’auricola sinistra: evidenze e possibili linee operative per un approccio collaborativo fra Cardiologia e Neurologia 164
La cardiomiopatia dilatativa non sempre è evolutiva: come evitare decisioni errate? 162
Thoracic pain: Clinical features 162
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 160
Nonatherosclerotic Coronary Artery Narrowing 159
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity 159
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 159
If heart failure or cardiac arrest complicate pregnancy and delivery 158
Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis 157
Insufficienza tricuspidale e indicazioni al trattamento 156
Effect of prehospital treatment in STEMI patients undergoing primary PCI 156
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 156
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT) 153
The evolution of cardiology: Changes, future challenges and opportunities 152
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study 148
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 147
Direct cellular reprogramming: the hopes and the hurdles 146
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 146
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry 144
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: Insights from the ATLANTIC trial 144
Early prognostic stratification and identification of irreversibly shocked patients despite primary percutaneous coronary intervention 143
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 142
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres 141
Cardiac amyloidosis: do not forget to look for it 140
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? 139
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 138
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction 138
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 136
null 135
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial 135
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery 134
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 134
Near-infrared spectroscopy-intravascular ultrasound: Scientific basis and clinical applications 133
Prognostic impact of treatments evolution in STEMI 131
null 131
International Subspecialty Fellowship Training, the Path for Cardiologists of Tomorrow?: A European Perspective 131
A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the “DAPT-STEMI trial” 131
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS 131
Supraventricular Tachycardia Causing Left Ventricular Dysfunction 129
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study 129
Implantable-cardioverter-defibrillator after ST-elevation myocardial infarction: when and how frequently is it implanted and what is the rate of appropriate interventions? Insight from Trieste registry 127
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut TAVR 126
The impact of COVID-19 on myocardial infarctions, strokes and out-of-hospital cardiopulmonary arrests: an observational retrospective study on time-sensitive disorders in the Friuli Venezia Giulia region (Italy) 123
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 123
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction 123
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 122
Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial 121
Might midodrine be useful in patients with decompensated and worsening chronic heart failure? Author's reply 120
In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure 120
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection 120
Natural history of spontaneous coronary dissections 119
Long-Term Follow-Up of a Nonprogressive Left Main Coronary Artery Fistula to Right Atrium 118
Totale 18.911
Categoria #
all - tutte 83.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021496 0 0 0 0 0 0 0 0 0 194 109 193
2021/20221.650 69 104 64 70 122 153 76 65 227 142 160 398
2022/20232.229 216 295 256 264 163 387 40 141 257 38 128 44
2023/20242.039 106 95 76 119 147 231 292 390 29 112 222 220
2024/20255.471 189 428 535 429 456 674 333 263 561 639 419 545
2025/202610.468 924 668 962 1.517 900 1.015 1.479 504 1.204 1.295 0 0
Totale 27.494